PDGF-D通过Notch1信号通路对肿瘤细胞上皮-间质转化调控作用的研究进展Research progress in regulatory effect of PDGF-D on epithelial-mesenchymal transition in tumor cells through Notch1 signaling pathway

doi:10.13481/j.1671-587X.20220134

Abstract

CLC Number:

R730.2

References 51

1	贾茗博，孙莹，赵丽艳. 血小板源生长因子在肿瘤侵袭、转移和上皮间质转化中作用的研究进展［J］. 中国实验诊断学， 2019， 23（6）： 1103-1107.
2	颉晚林，邹磊，孙轶华. PDGF-D及其相关信号传导通路在肿瘤发生发展中的作用［J］. 实用癌症杂志， 2019， 34（5）： 868-870.
3	钱丁丁，周建庆. PDGF-C和PDGF-D对心血管系统疾病影响的研究进展［J］. 浙江医学， 2019， 41（22）： 2440-2443.
4	CHEN J， YUAN W， WU L， et al. PDGF-D promotes cell growth， aggressiveness， angiogenesis and EMT transformation of colorectal cancer by activation of Notch1/Twist1 pathway［J］. Oncotarget， 2017， 8（6）： 9961-9973.
5	ZHANG H， SUN J D， YAN L J， et al. PDGF-D/PDGFRβ promotes tongue squamous carcinoma cell （TSCC） progression via activating p38/AKT/ERK/EMT signal pathway［J］. Biochem Biophys Res Commun， 2016， 478（2）： 845-851.
6	DEVARAJAN E， SONG Y H， KRISHNAPPA S，et al. Epithelial-mesenchymal transition in breast cancer lines is mediated through PDGF-D released by tissue-resident stem cells［J］. Int J Cancer， 2012， 131（5）： 1023-1031.
7	KIM M S， CHOI H S， WU M X， et al. Potential role of PDGFRβ-associated THBS4 in colorectal cancer development［J］. Cancers， 2020， 12（9）： 2533.
8	WANG Z， LI Y， KONG D， et al. The role of Notch signaling pathway in epithelial-mesenchymal transition （EMT） during development and tumor aggressiveness［J］. Curr Drug Targets， 2010， 11（6）： 745-751.
9	杨允，戴德. PDGF-D在肿瘤生长及肿瘤靶向VEGF治疗中的研究现状［J］. 海南医学，2014， 25（20）： 3042-3044.
10	REIGSTAD L J， VARHAUG J E， LILLEHAUG J R. Structural and functional specificities of PDGF-C and PDGF-D， the novel members of the platelet-derived growth factors family［J］. FEBS J， 2005， 272（22）： 5723-5741.
11	USTACH C V， KIM H R. Platelet-derived growth factor D is activated by urokinase plasminogen activator in prostate carcinoma cells［J］.Mol Cell Biol，2005，25（14）： 6279-6288.
12	HELDIN C H， ERIKSSON U， OSTMAN A. New members of the platelet-derived growth factor family of mitogens［J］.Arch Biochem Biophys， 2002， 398（2）： 284-290.
13	ROSKOSKI R. The role of small molecule platelet-derived growth factor receptor （PDGFR） inhibitors in the treatment of neoplastic disorders［J］. Pharmacol Res， 2018， 129： 65-83.
14	NAJY A J， JUNG Y S， WON J J， et al. Cediranib inhibits both the intraosseous growth of PDGF-D positive prostate cancer cells and the associated bone reaction［J］. Prostate， 2012， 72（12）： 1328-1338.
15	NORDBY Y， RICHARDSEN E， RAKAEE M， et al. High expression of PDGFR-β in prostate cancer stroma is independently associated with clinical and biochemical prostate cancer recurrence［J］. Sci Rep， 2017， 7： 43378.
16	LI H， FREDRIKSSON L， LI X， et al. PDGF-D is a potent transforming and angiogenic growth factor［J］. Oncogene， 2003， 22（10）： 1501-1510.
17	KESARI S. Understanding glioblastoma tumor biology： the potential to improve current diagnosis and treatments［J］. Semin Oncol， 2011， 38： S2-S10.
18	COLELLA B， FAIENZA F， DI BARTOLOMEO S. EMT regulation by autophagy： a new perspective in glioblastoma biology［J］. Cancers（Basel）， 2019，11（3）：312.
19	SHIH A H， HOLLAND E C. Platelet-derived growth factor （PDGF） and glial tumorigenesis［J］. Cancer Lett， 2006， 232（2）： 139-147.
20	LOKKER N A， SULLIVAN C M， HOLLENBACH S J，et al. Platelet-derived growth factor （PDGF） autocrine signaling regulates survival and mitogenic pathways in glioblastoma cells： evidence that the novel PDGF-C and PDGF-D ligands may play a role in the development of brain tumors［J］. Cancer Res， 2002， 62（13）： 3729-3735.
21	GONDI C S， VEERAVALLI K K， GORANTLA B， et al. Human umbilical cord blood stem cells show PDGF-D-dependent glioma cell tropism in vitro and in vivo ［J］. Neuro Oncol， 2010， 12（5）： 453-465.
22	THIERY J P， ACLOQUE H， HUANG R Y， et al. Epithelial-mesenchymal transitions in development and disease［J］. Cell， 2009， 139（5）： 871-890.
23	侯鑫. PDGF-D通过EMT参与吉西他滨在肝细胞癌中的耐药机制研究［D］. 蚌埠：蚌埠医学院， 2014.
24	AHMED N， MAINES-BANDIERA S， QUINN M A， et al. Molecular pathways regulating EGF-induced epithelio-mesenchymal transition in human ovarian surface epithelium［J］. Am J Physiol Cell Physiol， 2006， 290（6）： C1532-C1542.
25	GOTZMANN J， FISCHER A N， ZOJER M， et al. A crucial function of PDGF in TGF-beta-mediated cancer progression of hepatocytes［J］. Oncogene， 2006， 25（22）： 3170-3185.
26	STRUTZ F， ZEISBERG M， ZIYADEH F N， et al. Role of basic fibroblast growth factor-2 in epithelial-mesenchymal transformation［J］. Kidney Int， 2002， 61（5）： 1714-1728.
27	YANG L， LIN C， LIU Z R. P68 RNA helicase mediates PDGF-induced epithelial mesenchymal transition by displacing Axin from beta-catenin［J］. Cell， 2006， 127（1）： 139-155.
28	王永娟，谢肖立，姜慧卿，等.肝纤维化中上皮间质转化的调控及靶向治疗的研究进展［J］. 临床肝胆病杂志，2021，37（1）： 165-168.
29	DU C， ZHANG C， HASSAN S， et al. Protein kinase D1 suppresses epithelial-to-mesenchymal transition through phosphorylation of snail［J］. Cancer Res， 2010， 70（20）： 7810-7819.
30	SON H， MOON A. Epithelial-mesenchymal transition and cell invasion［J］. Toxicol Res，2010，26（4）： 245-252.
31	GHELDOF A， BERX G. Cadherins and epithelial-to-mesenchymal transition［J］. Prog Mol Biol Transl Sci， 2013， 116： 317-336.
32	KAHLERT U D， MACIACZYK D， DOOSTKAM S， et al. Activation of canonical WNT/β-catenin signaling enhances in vitro motility of glioblastoma cells by activation of ZEB1 and other activators of epithelial-to-mesenchymal transition［J］. Cancer Lett， 2012，325（1）： 42-53.
33	IWADATE Y. Epithelial-mesenchymal transition in glioblastoma progression［J］. Oncol Lett， 2016， 11（3）： 1615-1620.
34	ISER I C， PEREIRA M B， LENZ G， et al. The epithelial-to-mesenchymal transition-like process in glioblastoma： an updated systematic review and in silico investigation［J］. Med Res Rev， 2017， 37（2）： 271-313.
35	SINGH S K， CLARKE I D， TERASAKI M， et al. Identification of a cancer stem cell in human brain tumors［J］. Cancer Res， 2003， 63（18）： 5821-5828.
36	CARRO M S， LIM W K， ALVAREZ M J， et al. The transcriptional network for mesenchymal transformation of brain tumours［J］. Nature， 2010，463（7279）：318-325.
37	KONG D， WANG Z， SARKAR S H， et al. Platelet-derived growth factor-D overexpression contributes to epithelial-mesenchymal transition of PC3 prostate cancer cells［J］. Stem Cells， 2008， 26（6）： 1425-1435.
38	MIELE L， MIAO H， NICKOLOFF B J. NOTCH signaling as a novel cancer therapeutic target［J］. Curr Cancer Drug Targets， 2006， 6（4）： 313-323.
39	RANGANATHAN P， WEAVER K L， CAPOBIANCO A J. Notch signalling in solid tumours： a little bit of everything but not all the time［J］. Nat Rev Cancer， 2011， 11（5）： 338-351.
40	王闻楚. E-cadherin通过Notch信号通路介导前列腺癌耐药的分子机制［D］. 南宁：广西医科大学， 2015.
41	YI L， ZHOU X， LI T， et al. Notch1 signaling pathway promotes invasion， self-renewal and growth of glioma initiating cells via modulating chemokine system CXCL12/CXCR4［J］. J Exp Clin Cancer Res，2019，38（1）： 339.
42	JIANG L G， WU J， CHEN Q H， et al. Notch1 expression is upregulated in glioma and is associated with tumor progression［J］. J Clin Neurosci， 2011， 18（3）： 387-390.
43	LEONG K G， NIESSEN K， KULIC I， et al. Jagged1-mediated Notch activation induces epithelial-to-mesenchymal transition through Slug-induced repression of E-cadherin［J］. J Exp Med， 2007， 204（12）： 2935-2948.
44	游焜，王大军，王亮，等. 敲除NOR1基因对人肝癌裸鼠移植瘤的影响及作用机制［J］. 临床肝胆病杂志，2020，36（2）： 381-386.
45	BILLOTTET C， TUEFFERD M， GENTIEN D， et al. Modulation of several waves of gene expression during FGF-1 induced epithelial-mesenchymal transition of carcinoma cells［J］. J Cell Biochem， 2008， 104（3）： 826-839.
46	TIMMERMAN L A， GREGO-BESSA J， RAYA A， et al. Notch promotes epithelial-mesenchymal transition during cardiac development and oncogenic transformation［J］. Genes Dev， 2004， 18（1）： 99-115.
47	SAHLGREN C， GUSTAFSSON M V， JIN S， et al. Notch signaling mediates hypoxia-induced tumor cell migration and invasion［J］. PNAS， 2008， 105（17）： 6392-6397.
48	NIESSEN K， FU Y， CHANG L， et al. Slug is a direct Notch target required for initiation of cardiac cushion cellularization［J］. J Cell Biol， 2008， 182（2）： 315-325.
49	LI J L， LI Q B， LIN L， et al. Targeting the Notch1 oncogene by miR-139-5p inhibits glioma metastasis and epithelial-mesenchymal transition （EMT）［J］. BMC Neurol， 2018， 18（1）： 133.
50	赵林，张才全，廖刚，等. PDGF-D和VEGF在胃癌中的表达及其意义［J］.基础医学与临床，2009，29（12）： 1305-1309.
51	HUANG H. Matrix metalloproteinase-9 （MMP-9） as a cancer biomarker and MMP-9 biosensors： recent advances［J］. Sensors （Basel），2018， 18（10）：3249.

[1]	Pei GONG, Jingran LIU, Shimin ZHAO, Yuzhen WANG, Jiming XIE. Inhibitory effect of MCM10 silencing on proliferation of breast cancer MDA-MB-231 cells and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2021, 47(3): 652-659.
[2]	PEI Ying, ZOU Ying, BA Xiumin, LI Xu. Modified anterior lacrimal recess approach under nasal endoscope in treatment of primary malignant melanoma of lacrimal sac: A case report and literature review [J]. Journal of Jilin University(Medicine Edition), 2020, 46(04): 863-866.
[3]	YANG Zhiyuan, WEN Naiyan, LIN Yang, LIANG Hang, WANG Qian, HU Xindan, ZHANG Ling, REN Hui, GUO Baofeng. Inhibitory effect of SF2523 on proliferation of human glioma stem cells TS576 and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2019, 45(06): 1281-1287.
[4]	. Research progress in relationship between xCT and cancer and cancer stem cells [J]. Journal of Jilin University(Medicine Edition), 2019, 45(06): 1459-1464.
[5]	. Research progress in role of human bone marrow stromal antigen-2 in occurrence and development of tumor [J]. Journal of Jilin University(Medicine Edition), 2019, 45(04): 976-980.
[6]	. Research progress in generation and biological functions of exosome [J]. Journal of Jilin University(Medicine Edition), 2018, 44(05): 1109-1114.
[7]	ZHANG Yanxia, LI Yuehui, ZHANG Lihong, ZHANG Nianping, YAN Yanyan, YANG Xiaohui, FENG Xiangling. Effects of silencing HOXA13 gene on malignant phenotypes of hepatocellular carcinoma HepG₂ and QGY-7703 cells [J]. Journal of Jilin University Medicine Edition, 2018, 44(02): 315-320.
[8]	CAO Rangjuan, LI Kai, XING Wanying, WANG Yueshu, YU Wei, WU Guangzhi, CUI Shusen, LI Qiang. Expression of Disabled-1 in human breast cancer cells and its role in cell cycle [J]. Journal of Jilin University Medicine Edition, 2016, 42(05): 932-936.
[9]	YU Zhiyun, LI Yunqian, CHEN Yong, ZHAO Liyan, LIU Huanbing, WANG Nan, WANG Bin, CHEN Yunzhao, ZHAO Gang. Elimination of temozolomide in combination with metformin on glioma stem cells and its mechanism [J]. Journal of Jilin University Medicine Edition, 2015, 41(02): 321-326.
[10]	WU Min, ZHAO Hongguang, GUAN Feng, SA Ri, LIN Chenghe. Application of ¹⁸F-FDG PET-CT imaging in diagnosis of primary central nervous system lymphoma [J]. Journal of Jilin University Medicine Edition, 2015, 41(02): 401-404.
[11]	YANG Yanyan, JIN Minghua, LI Yanbo, LI Yang, WANG Jiahui, ZHENG Tong, WANG Sihui, CHI Xiangyu, ZHANG Yujia, SUN Zhiwei. Induction effect of nano- SiO₂ on apoptosis of neuroblastoma SH-SY5Y cells and its mechanism [J]. Journal of Jilin University Medicine Edition, 2015, 41(02): 249-254.
[12]	LIU Tong,LI Dan-ni*,LI Yang,LI Feng. Construction and expression of wild type and inactive type of GST-tagged eukaryotic expression vectors of PAK1 gene autoinhibitory domain [J]. Journal of Jilin University Medicine Edition, 2014, 40(01): 27-30.
[13]	SHU Chang，KAN Zhi-sheng，ZHU Yan-bing，CAO Li-ying. Correlation analysis on MRI quantitative parameters and expression level of HIF-1α in cerebral astrocytoma [J]. Journal of Jilin University Medicine Edition, 2013, 39(1): 109-112.
[14]	. Advance research on role of carcinoembryonic antigen-relatedcell adhesion molecule 1 in occurrence, development and metastasis of tumor  [J]. J4, 2012, 38(5): 1037-1042.
[15]	WANG Li-qun\| XU Ye\|JIN Ren-shun. Expressions \|of EGFR and TGF-α \|in prostatic adenocarcinoma and prostatic intraepithelial neoplasia tissues and their clinical significances [J]. J4, 2012, 38(2): 308-311.

RichHTML

PDF (PC)

Like

Knowledge

Abstract

Cite this article

share this article

References 51

Related Articles 15

Metrics

Comments

Recommended 10